NaturalShrimp’s Hydrenesis Technology Demonstrates Superior Performance at Hanilu Farms
DALLAS, TX, July 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the commercially operational RAS (Recirculating Aquaculture System), today reported the successful application of its Hydrenesis Technology at Hanilu Farms, a commercial aquaculture facility in Cutler, Indiana.
Founded in 2017, Hanilu Farms provides locally grown barramundi at its indoor recirculating aquaculture system (RAS) facility. The facility consists of 34 tanks and produces more than 900 kilograms of live fish per week, year-round. Natural Aquatic Systems, a wholly owned subsidiary of NaturalShrimp, works closely with Hanilu Farms. Founder Lealand Meador has contributed to research, data collection, automation and improvements of the Hydrenesis technology, in particular the hardware and its ruggedization.
Hydrenesis “Redox” water treatment technologies have the ability to affect water chemistry and elevate water quality, and they are proving to be critical technologies for scaling hatchery and nursery systems and impacting growth and health metrics. A recently completed trial at the independent RAS testing center Marineholmen RASLab in Norway evaluated how Hydrogas and electrocoagulation technologies compared with the traditional method of using a biofilter when raising salmon. Based on the results of this study, NaturalShrimp expects technology licensing opportunities to salmon and finfish producers worldwide.
“Our success with our early aquaculture partner Hanilu Farms using Hydrogas technology supports the significant potential for commercial licensing of the technology as an additional revenue stream,” said Gerald Easterling, CEO of NaturalShrimp. “The ability to increase health and survival rates in commercial facilities opens our opportunity to additional worldwide seafood markets, including salmon, barramundi, and other freshwater fish. Hanilu has noted that while using Hydrenesis, mortality rate goes down, the feed conversion ratio improves, and the fish grow faster. We are incredibly thankful for Hanilu Farms’ input as they utilized our technology, and we look forward to working with them as both companies scale operations.”
An article describing the successful use of Hydrenesis Technology at Hanilu Farms recently appeared in “The Fish Site”, a knowledge-sharing platform with premium news, analysis and resources for the aquaculture industries.
Article Link: Novel tech shows promise on US barramundi farm– The Fish Site
NaturalShrimp, Inc. is a publicly traded aquaculture Company, headquartered in Dallas, with production facilities located near San Antonio, Texas and Webster City, Iowa. The Company has developed the first commercially viable system for growing shrimp in enclosed, salt-water systems, using patented technology to produce fresh, never frozen, naturally grown shrimp, without the use of antibiotics or toxic chemicals. NaturalShrimp systems can be located anywhere in the world to produce gourmet-grade Pacific white shrimp. For more information visit www.naturalshrimp.com.
This press release contains a number of forward-looking statements that reflect management’s current views with respect to future events and financial performance. Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. These statements include statements regarding the intent, belief or current expectations of us and members of our management team, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks set forth in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, any of which may cause our company’s or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in our forward-looking statements.
Investor Relations Contact
Executive Vice President
MZ North America
Released July 14, 2022